Evaluation of adalimumab biosimilar in treatment of psoriatic arthritis with concomitant moderate to severe chronic plaque psoriasis: An open-labeled, prospective, pilot case series

We report the results of a prospective study evaluating the adalimumab biosimilar Exemptia (ZRC 3197; Zydus Cadi la, Gujarat, India) in PsA with concomitant psoriasis.

Source: Journal of the American Academy of Dermatology - February 18, 2020 Category: Dermatology Authors: Sujay Khandpur, Prateek Sondhi, Neha Taneja, Preeti Sharma, Dayasagar Das, Alpana Sharma, Vishnubatla Sreenivas Tags: Letter Source Type: research